Michael Blair, DO
Otolaryngology/Facial Plastic Surgery · San Marcos, TXNPI 1104037100
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Acclarent, Inc at 31.2% of the total. Reporting peaked in 2021 at $183 and has fallen 72.9% since, to $50 in 2025. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in TX, where the typical reported total is $1,846.
Across 27 payments — averaging $27.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acclarent, Inc$229
- Aerin Medical Inc.$111
- Sanofi$106
- Stryker$101
- Johnson & Johnson$41
- Baxter Healthcare$36
- plus $109 from 5 others
What the payments were for
- Food & beverage$733100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acclarent, Inc | 8 | $229 |
| Aerin Medical Inc. | 4 | $111 |
| Sanofi | 3 | $106 |
| Stryker | 4 | $101 |
| Johnson & Johnson | 2 | $41 |
| Baxter Healthcare | 1 | $36 |
| Boehringer Ingelheim | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Medicomp Inc | 1 | $20 |
| Olympus America Inc. | 1 | $17 |
| Smith+Nephew | 1 | $16 |
How this compares
$733 in reported general payments places this provider in the 20th percentile of 51 otolaryngology/facial plastic surgery providers in Texas.
See all otolaryngology/facial plastic surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Epinephrine | 50 | $10,940 |
| Azelastine Hcl | 171 | $4,487 |
| Fluticasone Propionate | 306 | $3,925 |
| Omeprazole | 78 | $1,537 |
| Famotidine | 47 | $918 |
| Montelukast Sodium | 70 | $724 |
| Ipratropium Bromide | 29 | $719 |
| Pantoprazole Sodium | 22 | $354 |
| Celecoxib | 20 | $313 |
| Oxycodone Hcl | 35 | $98 |
| Ondansetron Hcl | 38 | $69 |
| Amoxicillin | 12 | $40 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in San Marcos
- Yula IndeyevaAustin$579K
- Manuel LopezSan Antonio$55K
- Michel SiegelHouston$23K
- Etai FunkHouston$18K
- Jamie KuHouston$18K
- James AndrewsHouston$11K
- Daniel LeemanGeorgetown$10K
- Anand ShahSan Antonio$9K
- Russell BriggsAustin$9K
- Sneha GiriSouthlake$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.